REGISTERED NUMBER: 07024408 (England and Wales)

Unaudited Financial Statements

for the Year Ended

31 December 2024

for

Aspire Medical Group Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Ms J M O'Neill

Mrs C L Hunt

REGISTERED OFFICE:

The Old Bakehouse

Course Road

Ascot

Berkshire

SL5 7HL

REGISTERED NUMBER:

07024408 (England and Wales)

ACCOUNTANTS:

Jacksons Accountants (Ascot) Limited

The Old Bakehouse

Course Road

Ascot

Berkshire

SL5 7HL

FIXED ASSETS

Tangible assets

4

94,277

117,331

Investments

5

1

1

94,278

117,332

CURRENT ASSETS

Stocks

10,924

11,280

Debtors

6

13,688

52,791

Cash at bank

24,447

73,436

49,059

137,507

CREDITORS

Amounts falling due within one year

7

111,799

139,923

NET CURRENT LIABILITIES

(62,740

)

(2,416

)

TOTAL ASSETS LESS CURRENT LIABILITIES

31,538

114,916

CREDITORS

Amounts falling due after more than one year

8

(44,236

)

(71,974

)

PROVISIONS FOR LIABILITIES

(14,573

)

(19,439

)

NET (LIABILITIES)/ASSETS

(27,271

)

23,503

CAPITAL AND RESERVES

Called up share capital

800

800

Retained earnings

(28,071

)

22,703

SHAREHOLDERS' FUNDS

(27,271

)

23,503

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:

Ms J M O'Neill - Director

1.	STATUTORY INFORMATION

Aspire Medical Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover represents invoiced sales of goods and services.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost, 20% on cost and 10% on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2023 - 8 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

Office &

to

Medical

and

computer

property

equipment

fittings

equipmt

Totals

£

£

£

£

£

COST

At 1 January 2024

43,276

229,856

33,252

67,774

374,158

Additions

-

3,950

1,445

3,100

8,495

At 31 December 2024

43,276

233,806

34,697

70,874

382,653

DEPRECIATION

At 1 January 2024

26,921

133,797

32,106

64,003

256,827

Charge for year

1,908

27,551

558

1,532

31,549

At 31 December 2024

28,829

161,348

32,664

65,535

288,376

NET BOOK VALUE

At 31 December 2024

14,447

72,458

2,033

5,339

94,277

At 31 December 2023

16,355

96,059

1,146

3,771

117,331

5.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 January 2024

and 31 December 2024

1

NET BOOK VALUE

At 31 December 2024

1

At 31 December 2023

1

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Unpaid share capital

50

50

Other debtors

13,638

14,988

Directors' current accounts

-

37,753

13,688

52,791

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Bank loans and overdrafts

20,000

20,000

Trade creditors

57,786

93,065

Corporation Tax

26,021

17,257

Social security and other taxes

5,591

5,685

Other creditors

1

1

Sundry creditors

-

915

Accrued expenses

2,400

3,000

111,799

139,923

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.12.24

31.12.23

£

£

Bank loans - 1-2 years

10,000

20,000

Bank loans - 2-5 years

-

10,000

Other loans - 2-5 years

34,236

41,974

44,236

71,974

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

31.12.24

31.12.23

£

£

Ms J M O'Neill

Balance outstanding at start of year

37,753

45,470

Amounts advanced

-

37,753

Amounts repaid

(37,753

)

(45,470

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

-

37,753